Clearside Biomedical (CLSD) stock price, revenue, and financials

Clearside Biomedical market cap is $320.1 m, and annual revenue was $7.89 m in FY 2020

$320.1 M

CLSD Mkt cap, 21-Jul-2021

$34 K

Clearside Biomedical Revenue Q1, 2021
Clearside Biomedical Net income (Q1, 2021)-7.4 M
Clearside Biomedical EBIT (Q1, 2021)-8.3 M
Get notified regarding key financial metrics and revenue changes at Clearside BiomedicalLearn more
Banner background

Clearside Biomedical Balance Sheet

Annual

USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

20.3m34.8m9.2m8.0m22.6m17.3m

Prepaid Expenses

159.0k396.0k1.4m2.0m1.1m722.0k

Current Assets

20.5m84.3m39.2m42.9m25.2m18.1m

PP&E

156.0k94.0k885.0k790.0k541.0k416.0k

Total Assets

21.1m84.8m40.5m44.1m26.8m19.3m

Accounts Payable

1.5m2.6m5.4m6.9m1.3m2.0m

Short-term debt

1.7m3.2m556.0k1.3m991.0k

Current Liabilities

5.2m5.4m13.5m10.5m10.9m9.9m

Long-term debt

4.2m7.6m4.8m9.4m3.8m616.0k

Non-Current Liabilities

5.2m7.7m5.6m

Total Debt

6.0m7.6m8.0m10.0m5.2m1.6m

Total Liabilities

10.4m13.2m19.1m20.5m15.6m10.6m

Common Stock

3.0k25.0k25.0k32.0k44.0k52.0k

Additional Paid-in Capital

2.7m136.9m145.6m230.5m248.8m264.6m

Retained Earnings

(3.9m)(65.2m)(124.2m)(206.9m)(237.7m)(255.9m)

Total Equity

(36.7m)71.7m21.4m23.6m11.2m8.8m

Debt to Equity Ratio

0.1 x0.4 x0.4 x

Debt to Assets Ratio

0.1 x0.2 x0.2 x

Financial Leverage

-0.6 x1.2 x1.9 x1.9 x2.4 x2.2 x

Clearside Biomedical Cash Flow

Annual

USDFY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

(17.6m)(25.9m)(59.0m)(82.8m)(30.8m)(18.2m)

Depreciation and Amortization

60.0k65.0k182.0k189.0k211.0k180.0k

Accounts Payable

632.0k1.4m4.7m(314.0k)(5.6m)(631.0k)

Cash From Operating Activities

(13.9m)(22.7m)(51.1m)(79.2m)(27.1m)(13.1m)

Purchases of PP&E

(32.0k)(3.0k)(306.0k)(88.0k)(25.0k)(55.0k)

Cash From Investing Activities

(28.0k)(49.1m)20.1m(3.8m)32.9m(55.0k)

Long-term Borrowings

(6.3m)(8.3m)(5.0m)(5.3m)

Cash From Financing Activities

25.9m86.4m5.4m81.8m8.7m7.9m

Net Change in Cash

12.0m14.5m(25.6m)(1.2m)14.6m(5.3m)

Interest Paid

100.0k250.0k653.0k751.0k843.0k524.0k

Clearside Biomedical Ratios

USDFY, 2015

Financial Leverage

-0.6 x